Company attributes
Other attributes
Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.
Antheia was awarded two grants by the National Science Foundation (NSF): 1) SBIR Phase I: production of plant alkaloid therapeutics via fermentation of engineered yeast on June 20, 2016 with a value of $225,000, and 2) SBIR Phase II: A complete bioprocess for medicinal plant opioids on March 5, 2018 with a value of $733,952.
In 2017 Antheia received two grant awards, the Small Business and Innovation Research (SBIR) award and the Small Business Technology Transfer (STTR) award, from the National Institutes of Health (NIH) worth a total of $450,000.
On March 13, 2015 Antheia completed their seed funding round raising $1.97 million.
On May 26, 2017 Antheia completed their series A funding round raising $6,223,389.
